Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...

IRVING, Texas - McKesson Corporation (NYSE: NYSE:MCK), a $76 billion healthcare giant with "GREAT" financial health according to InvestingPro metrics, has entered into a definitive agreement to ...

This collaboration supports the "Protect Your Heart" national awareness campaign, sponsored by Bayer and Al-Dawaa Medical Services, and aligned with the Ministry of Health, and in collaboration with ...

Established in 1989 in Dubai, UAE, Zahrawi Group (MTC Company) is one of the leading and pioneer Medical Devices and Life ...

Tackles Xenophobia in 15th Inaugural Lecture By  Chinedu Adonu Godfrey Okoye University (GOUNI), Enugu, has cemented its ...

Physician–scientists at the University of Utah's John A. Moran Eye Center have published an investigatory review of nine patients who experienced vision complications while taking popular semaglutide ...

Melvin Mann, diagnosed with chronic myeloid leukemia in 1994, participated in a clinical trial for Imatinib that extended his ...

I worked closely with NCI’s Investigational Drug Branch (IDB) from 1990-2016, including as a principal investigator of one of ...

Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...

Aclarion (ACON) has secured full funding for its pivotal CLARITY trial which is designed to demonstrate Nociscan’s clinical and economic value ...

The Company has secured nearly $20 million in gross proceeds in 2025 ensuring complete funding for its pivotal CLARITY trialCLARITY is a ...